Lupus Nephritis (LN)

Dapagliflozin in Active Lupus Nephritis

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Dose Escalation Study With Bispecific Antibodies in Adult Patients With Lupus Nephritis

A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment

Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease

Research Accelerated by You Lupus Registry

Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN

Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus

BCMA-CD19 cCAR T for the Treatment of Refractory Lupus

Safety and Efficacy of ONT01 in Lupus

A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis

The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis

SGLT-2 Inhibitors on Albuminuria in Chronic Kidney Disease Patients With Lupus Nephritis and ANCA- Associated Vasculitis

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.